PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 2, 2013Annals of Surgery350 citations

Endovascular Repair Versus Open Repair of Ruptured Abdominal Aortic Aneurysms

View Full Paper
JRJ.J. ReimerinkLHL.L. HoornwegAVA.C. Vahl

Structured PICO

Does endovascular repair reduce the composite of death and severe complications at 30 days compared to open repair in patients with ruptured abdominal aortic aneurysms?

P
Population
116 patients with a ruptured abdominal aortic aneurysm (RAAA) fit for both endovascular repair and open repair, from the larger Amsterdam area.
I
Intervention
Endovascular repair (EVAR)
C
Comparator
Open repair (OR)
O
Outcome
Composite of death and severe complications at 30 dayscomposite

In patients with ruptured abdominal aortic aneurysms, endovascular repair did not significantly reduce the 30-day composite of death and severe complications compared to open repair.

Abstract

OBJECTIVE: Randomized comparison of endovascular repair (EVAR) with open repair (OR) in patients with a ruptured abdominal aortic aneurysm (RAAA). BACKGROUND: Despite advances in operative technique and perioperative management RAAA remains fraught with a high rate of death and complications. Outcome may improve with a minimally invasive surgical technique: EVAR. METHODS: All patients with a RAAA in the larger Amsterdam area were identified. Logistics for RAAA patients was changed with centralization of care in 3 trial centers. Patients both fit for EVAR and for OR were randomized to either of the treatments. Nonrandomized patients were followed in a prospective cohort. Primary endpoint of the study was the composite of death and severe complications at 30 days. RESULTS: Between April 2004 and February 2011, we identified 520 patients with a RAAA of which 116 could be randomized. The primary endpoint rate for EVAR was 42% and for OR was 47% absolute risk reduction (ARR) = 5.4%; 95% confidence interval (CI): -13% to +23%. The 30-day mortality was 21% in patients assigned to EVAR compared with 25% for OR (ARR = 4.4% 95% CI: -11% to +20%). The mortality of all surgically treated patients in the nonrandomized cohort was 30% (95% CI: 26%-35%) and 26% (95% CI: 20% to 32%) in patients with unfavorable anatomy for EVAR, treated by OR at trial centers. CONCLUSIONS: This trial did not show a significant difference in combined death and severe complications between EVAR and OR. Mortality for OR both in randomized patients and in cohort patients was lower than anticipated, which may be explained by optimization of logistics, preoperative CT imaging, and centralization of care in centers of expertise.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Reimerink et al. (2013) studied this question.

synapsesocial.com/papers/69f7e3f2a00cd75688a510eehttps://doi.org/10.1097/sla.0b013e31828d4b76
Ask AI
Helpful
Bookmark
Share
View Full Paper